Mallinckrodt Pharmaceuticals
Overview
Mallinckrodt Pharmaceuticals is a global specialty pharmaceutical company that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. The company focuses on areas with high unmet medical needs, such as autoimmune and rare diseases as well as providing a variety of pain management solutions.
Therapeutic areas
FDA compliance signals
2 FDA enforcement records linked to this company.
- recall — Class II2019-05-29
Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.
- recall — Class II2019-05-29
Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.
Is this Mallinckrodt Pharmaceuticals? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.